The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s hemostasis diagnostic devices and equipment market report forecasts the hemostasis diagnostic devices and equipment market size to grow to $8 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Hemostasis Diagnostic Devices And Equipment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Size Forecast

The global hemostasis diagnostic devices and equipment market is expected to grow from $4.77 billion in 2022 to $5.4 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hemostasis diagnostic devices and equipment market size is expected to grow to $8 billion in 2027 at a CAGR of 10.3%.

North America held the largest hemostasis diagnostic devices and equipment market share.

Key Hemostasis Diagnostic Devices And Equipment Market Driver ­– Increased Likelihood Of Older People Being Diagnosed With A Disease

Due to the higher incidence of diseases with advancing age, there is an increase in the number of surgeries in elderly patients nowadays. These hemostasis devices are very efficient in speeding up the natural process of clotting in the blood and can monitor anticoagulation and transfusion therapy guidance in any surgery.

Request for A Sample Of The Global Hemostasis Diagnostic Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp

Key Hemostasis Diagnostic Devices And Equipment Market Trend – Emerging Of New And Improved Technology

The emergence of new and improved technology in the hemostasis diagnostic device and equipment market. To improve the quality and success rate of operations, new and improved technology such as the collagen vascular hemostasis devices have been implemented. Collagen is the main structural protein found in skin and other connective tissues. It is widely used in purified form for cosmetic surgical treatments and has now emerged in the hemostasis diagnostic devices market. A patient can face immobility right after a femoral surgery leading to increased discomfort, as a result, collagen-based closure devices have been implemented. According to a study conducted by the American Journal of Neuroradiology which they surveyed 698 Angio-Seal closures, using the Angio seal reduced the average time before mobilization by close to 15 minutes with no major complications. Angio seal is a type of collagen hemostasis device which reduces the average time of hemostasis and betters the mobilization of the patient.

Hemostasis Diagnostic Devices And Equipment Market Segment

1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits

2) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users

3) By Device Technology: Automated, Semi-Automated, Manual

Hemostasis Diagnostic Devices And Equipment Market Major Players and Strategies

Major players in the hemostasis diagnostic devices and equipment market are C.R. Bard, Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton, Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, and F. Hoffmann-La Roche Ltd.

In 2021, Baxter International Inc., a leading global medical products company, has announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc for up to $60.8 million, as well as $25 million paid upfront. This acquisition helps the transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio. CryoLife, Inc. is one of the world’s leading contemporary medical device companies.

The Hemostasis Diagnostic Devices And Equipment Global Market Report 2023 covers regional data on hemostasis diagnostic devices and equipment market size, hemostasis diagnostic devices and equipment market trends and drivers, opportunities, strategies, and hemostasis diagnostic devices and equipment market competitor analysis. The countries covered in the hemostasis diagnostic devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Hemostasis is the process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. With the help of hemostasis diagnostic devices, the cause of bleeding during surgery can be predicted by identifying any hemostatic defects in patients.

View More Reports Related To The Hemostasis Diagnostic Devices And Equipment Market –

Hemostasis Analyzers Global Market Report 2023

Hematology Analyzers And Reagents Global Market Report 2023

Hematology Diagnostic Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: